Pri-Med Atlanta | October 2025

Wednesday−Thursday, October 29–30|Atlanta, GA

Pri-Med Atlanta - Regional CME/CE Conference

Wednesday, October 29 2025

12:40–1:25pm

Industry Theater

A Treatment Option for Appropriate Patients With Uncontrolled Moderate-to-Severe Atopic Dermatitis

Description

Learn more about a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis (AD).

Faculty

Sponsored by

  • Sanofi and Regeneron Pharmaceuticals, Inc.